{"id":"W2087700674","doi":"10.1111/bjh.12274","title":"The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Randomization; International Prognostic Scoring System; Population; Polycythaemia; Gastroenterology; Clinical trial; Surgery; Myelodysplastic syndromes; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009733957,0.0002473009,0.002928586,0.0002898816,0.000115038,0.00004426667,0.0002046289,0.0001412648,0.00004498064],"category_scores_gemma":[0.001055829,0.0001623584,0.0005756706,0.0005677966,0.0003242596,0.0001358895,0.00007521389,0.0003730443,0.000002972405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005775711,"about_ca_system_score_gemma":0.0001245087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004298924,"about_ca_topic_score_gemma":0.00127826,"domain_scores_codex":[0.9953929,0.0004705252,0.002736436,0.0003020692,0.0006480793,0.0004500165],"domain_scores_gemma":[0.9937144,0.00238756,0.001996243,0.000313458,0.00135347,0.0002348868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004040421,0.01172482,0.9575634,0.000033601,0.006253044,0.001247816,0.001334692,0.0000354461,0.000004781076,0.00004740422,0.0003280648,0.01738653],"study_design_scores_gemma":[0.07965677,0.01111609,0.9012126,0.0003646775,0.002458194,0.000904132,0.003819373,0.00008552207,0.0002298783,0.00003877349,0.00004457157,0.00006936784],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964891,0.001200037,0.00001685894,0.0001220208,0.0001159454,0.001899831,0.00006574833,0.000004870242,0.00008559546],"genre_scores_gemma":[0.9990177,0.0003861478,0.0002669072,0.00008547468,0.00002836013,0.0001523674,0.00001697114,0.00002143671,0.00002470024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07561635,"threshold_uncertainty_score":0.6620784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01525759521435154,"score_gpt":0.3194535140610985,"score_spread":0.3041959188467469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}